Cargando…
Survival after HeartMate 3 left ventricular assist device implantation: real‐world data from Europe
Autores principales: | Numan, Lieke, Schramm, Rene, Oerlemans, Marish I.F.J., van der Kaaij, Niels P., Aarts, Emmeke, Ramjankhan, Faiz Z., Oppelaar, Anne‐Marie, Morshuis, Michiel, Guenther, Sabina P.W., Zimpfer, Daniel, Riebandt, Julia, Wiedemann, Dominik, Asselbergs, Folkert W., Van Laake, Linda W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375103/ https://www.ncbi.nlm.nih.gov/pubmed/37394283 http://dx.doi.org/10.1002/ehf2.14444 |
Ejemplares similares
-
Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
por: Numan, Lieke, et al.
Publicado: (2023) -
Propensity score‐based analysis of long‐term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support
por: Numan, Lieke, et al.
Publicado: (2021) -
Monitoring left ventricular assist device parameters to detect flow- and power-impacting complications: a proof of concept
por: Moazeni, Mehran, et al.
Publicado: (2023) -
Donor-Derived Testicular Germ Cell Cancer in a Heart Transplant Recipient
por: Oerlemans, Marish I.F.J., et al.
Publicado: (2021) -
Developing a personalized remote patient monitoring algorithm: a proof-of-concept in heart failure
por: Moazeni, Mehran, et al.
Publicado: (2023)